These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32765654)

  • 1. miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression.
    Wu Y; Tao L; Liang J; Qiao Y; Liu W; Yu H; Yu X; Liu L
    Exp Ther Med; 2020 Aug; 20(2):952-960. PubMed ID: 32765654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1.
    Wang G; Dong Y; Liu H; Ji N; Cao J; Liu A; Tang X; Ren Y
    Oncol Lett; 2019 Oct; 18(4):3837-3844. PubMed ID: 31579087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of microRNA-620 facilitates the resistance of triple negative breast cancer cells to gemcitabine treatment by targeting DCTD.
    Wu C; Zhao A; Tan T; Wang Y; Shen Z
    Exp Ther Med; 2019 Jul; 18(1):550-558. PubMed ID: 31258693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-205-5p downregulation decreases gemcitabine sensitivity of breast cancer cells via ERp29 upregulation.
    Ma C; Shi X; Guo W; Feng F; Wang G
    Exp Ther Med; 2019 Nov; 18(5):3525-3533. PubMed ID: 31602229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN.
    Xia X; Zhang K; Luo G; Cen G; Cao J; Huang K; Qiu Z
    Am J Transl Res; 2017; 9(4):1886-1895. PubMed ID: 28469793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway.
    Xia XY; Yu YJ; Ye F; Peng GY; Li YJ; Zhou XM
    Neoplasma; 2020 Mar; 67(2):344-353. PubMed ID: 31973537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM).
    Fan X; Zhou S; Zheng M; Deng X; Yi Y; Huang T
    Biomed Pharmacother; 2017 Apr; 88():507-514. PubMed ID: 28126676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-372-3p promotes the epithelial-mesenchymal transition in breast carcinoma by activating the Wnt pathway.
    Fan X; Huang X; Li Z; Ma X
    J BUON; 2018; 23(5):1309-1315. PubMed ID: 30570852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation
    Deng D; Ye X; Wang X; He G
    RSC Adv; 2019 Jun; 9(35):20385-20394. PubMed ID: 35514680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Peng X; Yan B; Shen Y
    Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-590-3P suppresses cell survival and triggers breast cancer cell apoptosis via targeting sirtuin-1 and deacetylation of p53.
    Abdolvahabi Z; Nourbakhsh M; Hosseinkhani S; Hesari Z; Alipour M; Jafarzadeh M; Ghorbanhosseini SS; Seiri P; Yousefi Z; Yarahmadi S; Golpour P
    J Cell Biochem; 2019 Jun; 120(6):9356-9368. PubMed ID: 30520099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-431 serves as a tumor inhibitor in breast cancer through targeting FGF9.
    Wang W; Dong Y; Li X; Pan Y; Du J; Liu D
    Oncol Lett; 2020 Jan; 19(1):1001-1007. PubMed ID: 31897213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-221-3p is down-regulated in preeclampsia and affects trophoblast growth, invasion and migration partly via targeting thrombospondin 2.
    Yang Y; Li H; Ma Y; Zhu X; Zhang S; Li J
    Biomed Pharmacother; 2019 Jan; 109():127-134. PubMed ID: 30396069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer.
    Han X; Li Q; Liu C; Wang C; Li Y
    J Cell Biochem; 2019 Aug; 120(8):12966-12976. PubMed ID: 31001849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
    Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
    J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1.
    Gao J; Wu N; Liu X; Xia Y; Chen Y; Li S; Deng Z
    Exp Ther Med; 2018 Jun; 15(6):5205-5214. PubMed ID: 29904404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.